BURLINGTON, ON, Nov. 5, 2013 /CNW/ - EcoSynthetix Inc. (TSX:ECO)
("EcoSynthetix" or the "Company"), a renewable chemicals company
that produces a family of commercially proven bio-based products,
today announced its financial results for the three and nine months
ended September 30, 2013. Financial
references are in U.S. dollars unless otherwise indicated.
Third Quarter 2013 Highlights
- Net sales were $5.4 million for
the three months ended September 30,
2013 (Q3 2013), compared to $5.9
million for the three months ended September 30, 2012 (Q3 2012)
- Won five new customers year-to-date (YTD) and eight new
customers in the last twelve months (LTM)
- 25% growth in sales on a year-to-date basis
- Launched new products within the paper and paperboard
market
- Accelerated the trials and testing on product development
within the insulation and wood-based panel industries
"The opportunity for our EcoSphere biolatex
binders remains as strong as ever," said John van Leeuwen, Chief Executive Officer of
EcoSynthetix. "We are innovating in existing markets and trialing
in new markets. We launched new products during the quarter with
our paper and paperboard customers and we are accelerating the
trials with our new product applications within the building
materials industry."
Financial Summary
Net Sales
Net sales for the three months ended
September 30, 2013 (Q3 2013) were
$5.4 million compared to $5.9 million for the three months ended
September 30, 2012 (Q3 2012), a
change of $0.5 million. The change
was due to lower sales volume in Asia
Pacific of $2.0 million and
Europe/Middle East/Africa (EMEA) of $0.1
million, partly offset by higher sales volume in
North America and Latin America of $1.4
million and $0.2 million,
respectively.
Net sales for the year-to-date (YTD) period were
$17.1 million compared to
$13.6 million in the same period last
year, an increase of $3.4 million or
25%. The increase in net sales is principally due to a $3.4 million sales increase in North America, a $0.9
million sales increase in EMEA and a $0.5 million sales increase in Latin America, which were partly offset by a
$1.4 million decrease in sales in
Asia Pacific.
EcoSynthetix has won eight new customers since
Q3 2012. Collectively, these new customers accounted for 16% of net
sales during the quarter and on a YTD basis. These eight
customers accounted for a 14% and 20% increase in sales during the
three and nine months ended September 30,
2013 compared to the same period last year,
respectively.
Sales to existing customers represented a 22%
decrease and a 5% increase during the three and nine months ended
September 30, 2013 compared to the
same periods last year, respectively. The decrease in sales
to existing customers during the third quarter of fiscal 2013 was a
result of lower sales in Asia
Pacific. Sales decreased in Asia Pacific due to the timing of inventory
purchases by a distributor in this region in addition to
unfavorable market dynamics caused by the global over-supply of
butadiene and the related drop in butadiene and SB latex
prices.
Gross Profit
Gross profit was $0.8
million or 15.5% of sales in Q3 2013 compared to
$1.3 million or 21.6% of sales in the
same period last year. The change in gross profit was principally
due to higher manufacturing production costs, lower sales volume,
increased corn starch costs and lower selling prices.
For the YTD period, gross profit was
$2.7 million or 15.9% of sales
compared to $2.7 million or 19.6% of
sales in the same period last year. Increases in sales volume were
offset by increased corn starch costs, lower selling prices, higher
manufacturing production costs and increased manufacturing
depreciation. The change in gross profit as a percentage of sales
was principally due to increased corn starch costs, lower selling
prices and higher manufacturing production costs.
Gross profit as a percentage of sales, adjusted
for manufacturing depreciation, was 20.4% and 20.8% for Q3 2013 and
YTD, respectively, compared with 26.2% and 24.7% for the
corresponding periods last year.
Selling, General and Administrative
(Excludes share-based compensation, depreciation and
amortization and foreign exchange loss or gain)
Selling, general and administrative (SG&A)
costs were $2.8 million in Q3 2013
compared to $2.6 million in the same
period last year. For the YTD period, SG&A costs were
$8.7 million compared to $7.3 million for the same period last year. The
change was principally due to increased headcount.
Research and Development
Research and development (R&D) costs were
$1.4 million in Q3 2013 compared to
$0.8 million for the same period last
year. For the YTD period, R&D costs were $3.9 million compared to $2.9 million for the same period last year.
R&D is a key focus of EcoSynthetix to enhance its bio-based
material product portfolio and expand into new applications and
markets. The increase in R&D expenses reflects the Company's
ongoing investment in product development and innovation.
Adjusted EBITDA1
Adjusted EBITDA was ($3.2) million in Q3 2013, compared to
$(1.8) million in the same period
last year. For the YTD period, adjusted EBITDA was ($9.2) million compared to ($6.8) million in the same period last year. The
increase in adjusted EBITDA loss was primarily due to higher
operating expenses including SG&A and R&D.
Net Loss
Net loss in Q3 2013 was $4.0 million, or $0.07 per common share (basic and fully diluted),
compared to a net loss of $2.3
million, or $0.04 per common
share (basic and fully diluted), for same period last year. For the
YTD period, net loss was $11.1
million, or $0.20 per share
(basic and fully diluted) compared to $8.0
million or $0.15 per share
(basic and fully diluted) in the prior period.
Liquidity
Working capital was $90.5
million at September 30, 2013,
compared to working capital of $100.2
million at December 31,
2012. The change was principally due to cash utilized
in operating and investing activities.
Notice of Conference Call
EcoSynthetix will host a conference call on
Wednesday, November 6, 2013, at
8:30 AM ET to discuss its financial
results. John van Leeuwen,
CEO, and Robert Haire, CFO, will
co-chair the call. All interested parties can join the call by
dialing (647) 427-7450 or (888) 231-8191. Please dial in 15 minutes
prior to the call to secure a line. A live audio webcast of the
conference call will also be available at www.ecosynthetix.com. The
presentation will be accompanied by slides, which will be available
via the webcast link and the Company's website. Please connect at
least 15 minutes prior to the conference call to ensure adequate
time for any software download that may be required to join the
webcast.
1Non-IFRS Financial
Measures
This press release makes reference to certain
non-IFRS measures. These non-IFRS measures are not recognized
measures under IFRS, do not have a standardized meaning prescribed
by IFRS and are therefore unlikely to be comparable to similar
measures presented by other companies. Rather, these measures are
provided as additional information to complement those IFRS
measures by providing a further understanding of results of
operations of EcoSynthetix from management's perspective.
Accordingly, they should not be considered in isolation nor as a
substitute for analysis of the financial information of
EcoSynthetix reported under IFRS. The Company uses non-IFRS
measures such as Adjusted EBITDA to provide investors with a
supplemental measure of operating performance and thus highlight
trends in its core business that may not otherwise be apparent when
relying solely on IFRS financial measures. Management also believes
that securities analysts, investors and other interested parties
frequently use non-IFRS measures in the evaluation of issuers.
Management also uses non-IFRS measures in order to facilitate
operating performance comparisons from period to period, prepare
annual operating budgets and assess the Company's ability to meet
its capital expenditure and working capital requirements.
Adjusted EBITDA is not a measure recognized
under IFRS and does not have a standardized meaning prescribed by
IFRS. The Company presents Adjusted EBITDA because the Company
believes it facilitates investors' use of operating performance
comparisons from period to period and company to company by backing
out potential differences caused by variations in capital
structures (affecting relative interest expense), the book
amortization of intangibles (affecting relative amortization
expense) and the age and book value of property and equipment
(affecting relative depreciation expense). The Company also
presents Adjusted EBITDA because it believes it is frequently used
by securities analysts, investors and other interested parties as a
measure of financial performance. Adjusted EBITDA as presented
herein is not a recognized measure under IFRS and should not be
considered as an alternative to operating income or net income as a
measure of operating results or an alternative to cash flows as a
measure of liquidity. Adjusted EBITDA is defined as consolidated
net income (loss) before interest, income taxes, depreciation,
amortization, other non-cash expenses and charges which include the
movement in the unrealized gains and losses on the Company's
redeemable preferred shares and warrants classified as financial
liabilities prior to the initial public offering and share based
compensation expense.
The following table reconciles net loss to Adjusted EBITDA for
Q3 2013 and Q3 2012:
|
|
|
|
|
|
Three months
ended |
|
September 30, 2013 |
September 30, 2012 |
Net loss |
(3,960,546) |
(2,324,278) |
Depreciation and
amortization |
387,337 |
320,883 |
Share-based compensation |
477,000 |
285,000 |
Interest
Income |
(90,675) |
(85,727) |
Adjusted
EBITDA (1) |
(3,186,884) |
(1,804,122) |
About EcoSynthetix Inc. (www.ecosynthetix.com)
EcoSynthetix Inc. is a renewable chemicals company specializing in
bio-based products that can be used as inputs in industrial
manufacturing for a wide range of consumer products. The Company's
products offer a reduced carbon footprint and are marketed
primarily on the basis of lower cost, stable pricing and equal or
superior performance. EcoSynthetix's lead product,
EcoSphere® biolatex® binders, is used
commercially by a number of the global top 20 manufacturers in the
coated paper and paperboard industry.
Forward Looking Statements
Certain statements in this Press Release constitute "forward
looking" statements that involve known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance, objectives or achievements of the Company, or industry
results, to be materially different from any future results,
performance, objectives or achievements expressed or implied by
such forward looking statements. These statements reflect our
current views regarding future events and operating performance and
are based on information currently available to us, and speak only
as of the date of this Press Release. These forward looking
statements involve a number of risks, uncertainties and assumptions
and should not be read as guarantees of future performance or
results, and will not necessarily be accurate indications of
whether or not such performance or results will be achieved. Those
assumptions and risks include, but are not limited to, the fact
that our results of operations and business outlook are subject to
significant risk, volatility and uncertainty. Many factors could
cause our actual results, performance or achievements to be
materially different from any future results, performance or
achievements that may be expressed or implied by such forward
looking statements, including the factors identified in the "Risk
Factors" section of the Company's Annual Information Form dated
March 28, 2013. Should one or more of
these risks or uncertainties materialize, or should assumptions
underlying the forward looking statements prove incorrect, actual
results may vary materially from those described in this Press
Release as intended, planned, anticipated, believed, estimated or
expected. Unless required by applicable securities law, we do not
intend and do not assume any obligation to update these forward
looking statements.
EcoSynthetix Inc. |
|
|
|
Interim Consolidated Balance
Sheet |
|
|
|
(Expressed in U.S. dollars),
unaudited |
|
|
|
|
|
|
|
|
As at
September 30,
2013 |
|
As at
December 31,
2012 |
|
|
|
|
Assets |
|
|
|
Current assets |
|
|
|
|
Cash |
83,908,774 |
|
93,260,296 |
|
Accounts receivable |
3,841,001 |
|
4,309,355 |
|
Inventory |
7,270,598 |
|
6,822,619 |
|
Government grants receivable |
180,949 |
|
184,118 |
|
Prepaid expenses |
354,041 |
|
154,492 |
|
95,555,363 |
|
104,730,880 |
|
|
|
|
Non-current assets |
|
|
|
Intangible assets |
141,840 |
|
163,501 |
Property, plant and
equipment |
13,212,664 |
|
13,174,416 |
Total assets |
108,909,867 |
|
118,068,797 |
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
Accounts payable and accrued
liabilities |
5,013,775 |
|
4,282,296 |
|
Deferred government grant |
- |
|
226,920 |
|
5,013,775 |
|
4,509,216 |
|
|
|
|
Shareholders' Equity |
|
|
|
Common shares |
492,557,906 |
|
492,065,820 |
Contributed surplus |
7,804,503 |
|
6,831,354 |
Accumulated deficit |
(396,466,317) |
|
(385,337,593) |
Total shareholders'
equity |
103,896,092 |
|
113,559,581 |
|
|
|
|
Total shareholders'
equity and liabilities |
108,909,867 |
|
118,068,797 |
EcoSynthetix Inc. |
|
|
|
|
|
|
|
Interim Consolidated Statement of Operations and
Loss |
|
|
|
|
|
|
(Expressed in U.S. dollars,
unless otherwise noted), unaudited |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, |
|
Nine months ended September 30, |
|
2013 |
|
2012 |
|
2013 |
|
2012 |
|
|
|
|
|
|
|
|
Net sales |
5,416,621 |
|
5,915,571 |
|
17,070,777 |
|
13,628,684 |
Cost of sales |
4,579,748 |
|
4,635,044 |
|
14,357,296 |
|
10,963,579 |
Gross profit on sales |
836,873 |
|
1,280,527 |
|
2,713,481 |
|
2,665,105 |
|
|
|
|
|
|
|
|
Expenses |
|
|
|
|
|
|
|
|
Selling, general and
administrative |
3,450,071 |
|
2,858,091 |
|
10,175,132 |
|
8,112,548 |
|
Research and development |
1,438,023 |
|
832,441 |
|
3,936,976 |
|
2,863,938 |
|
4,888,094 |
|
3,690,532 |
|
14,112,108 |
|
10,976,486 |
Loss from operations |
(4,051,221) |
|
(2,410,005) |
|
(11,398,627) |
|
(8,311,381) |
|
|
|
|
|
|
|
|
Interest income |
90,675 |
|
85,727 |
|
269,903 |
|
275,003 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss and comprehensive loss |
(3,960,546) |
|
(2,324,278) |
|
(11,128,724) |
|
(8,036,378) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted loss per common
share |
(0.07) |
|
(0.04) |
|
(0.20) |
|
(0.15) |
Weighted average
number of common shares outstanding |
55,764,273 |
|
55,324,997 |
|
56,026,829 |
|
55,273,916 |
EcoSynthetix Inc. |
|
|
|
|
|
|
Interim Consolidated Statements of Cash
Flows |
|
|
|
|
|
|
(Expressed in U.S. dollars), unaudited |
|
|
|
|
|
|
|
Three months
ended September 30, |
|
|
Nine months ended September 30, |
|
2013 |
2012 |
|
|
2013 |
2012 |
Cash provided by (used in) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating activities |
|
|
|
|
|
|
Net loss and comprehensive loss |
(3,960,546) |
(2,324,278) |
|
|
(11,128,724) |
(8,036,378) |
Items not affecting cash |
|
|
|
|
|
|
|
Depreciation and amortization |
387,337 |
320,883 |
|
|
1,134,941 |
822,815 |
|
Share-based compensation |
477,000 |
285,000 |
|
|
1,093,979 |
702,104 |
Changes in non-cash working capital |
|
|
|
|
|
|
|
Accounts receivable |
739,527 |
(1,695,334) |
|
|
468,354 |
(1,349,326) |
|
Inventory |
387,133 |
899,309 |
|
|
(329,435) |
2,740,832 |
|
Government grants receivable |
(4,429) |
188,579 |
|
|
3,169 |
201,468 |
|
Prepaid expenses |
34,993 |
(32,577) |
|
|
(199,549) |
(31,542) |
|
Accounts payable and accrued liabilities |
1,309,383 |
474,414 |
|
|
1,189,479 |
(648,533) |
|
Deferred government grant |
(82,918) |
224,023 |
|
|
(226,920) |
224,023 |
|
(712,520) |
(1,659,981) |
|
|
(7,994,706) |
(5,374,537) |
|
|
|
|
|
|
|
Investing activities |
|
|
|
|
|
|
Cash used for purchase of intangible assets,
property, plant and equipment |
(485,137) |
(626,805) |
|
|
(1,728,072) |
(5,344,799) |
|
|
|
|
|
|
|
Financing activities |
|
|
|
|
|
|
Repurchase of common shares |
- |
(521,729) |
|
|
- |
(521,729) |
Exercise of common share options |
33,260 |
123,463 |
|
|
275,957 |
141,784 |
Exercise of warrants |
95,299 |
|
|
|
95,299 |
- |
|
128,559 |
(398,266) |
|
|
371,256 |
(379,945) |
|
|
|
|
|
|
|
Change in cash during the period |
(1,069,098) |
(2,685,052) |
|
|
(9,351,522) |
(11,099,281) |
|
|
|
|
|
|
|
Cash - Beginning of period |
84,977,872 |
97,299,476 |
|
|
93,260,296 |
105,713,705 |
Cash - End of period |
83,908,774 |
94,614,424 |
|
|
83,908,774 |
94,614,424 |
SOURCE EcoSynthetix Inc.